At what point in drug development must a firm look to process optimization, and how critical is this timing to a product’s overall success? | CPhI North America

CPhI North America is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

 

View, browse and sort the ever-growing list of sessions by pass type, track, and format. With this Session Scheduler, you can build your schedule in advance and access it during the show via export or with the Mobile App, once live. Sessions do fill up and seating is first come, first serve, so arrive early to sessions that you would like to attend.

At what point in drug development must a firm look to process optimization, and how critical is this timing to a product’s overall success?

Dan Staton (Co-founder and Editor, BioProcess Insider)

Eric Langer (Managing Partner, BioPlan Associates)

Kelsey Achenbach (Head of Marketing - Pharmaceuticals, Roquette)

Location: bioLIVE Theater

Date: Wednesday, May 1

Time: 2:00pm - 2:45pm

Vault Recording: TBD